Biopharmaceutical
Canada
Innovation
Therapies
Collaboration
Licensing
Us
Focused
M&A Advisory
Lazard
Full Credential Description
Theratechnologies. Canada. Announced Date 29/10/2008. Closed Date 16/12/2008. Deal value: $215m. Theratechnologies and EMD Serono enter into collaboration and licensing agreement for Tesamorelin in the US. Industry: Theratechnologies is a biopharmaceutical company focused on developing and commercializing innovative therapies for unmet medical needs.